TY - JOUR
T1 - Preoperative CT predictors of survival in patients with pancreatic ductal adenocarcinoma undergoing curative intent surgery
AU - Dickinson, Shannan M.
AU - McIntyre, Caitlin A.
AU - Schilsky, Juliana B.
AU - Harrington, Kate A.
AU - Gerst, Scott R.
AU - Flynn, Jessica R.
AU - Gonen, Mithat
AU - Capanu, Marinela
AU - Wong, Winston
AU - Lawrence, Sharon
AU - Allen, Peter J.
AU - O’Reilly, Eileen M.
AU - Jarnagin, William R.
AU - D’Angelica, Michael I.
AU - Balachandran, Vinod P.
AU - Drebin, Jeffrey A.
AU - Kingham, T. Peter
AU - Simpson, Amber L.
AU - Do, Richard K.
N1 - Publisher Copyright:
© 2020, Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2021/4
Y1 - 2021/4
N2 - Purpose: To evaluate the associations between computed tomography (CT) imaging features extracted from the structured American Pancreatic Association (APA)/Society of Abdominal Radiology (SAR) template and overall survival in patients with resected pancreatic ductal adenocarcinoma (PDAC). Methods: This retrospective analysis included consecutive patients with PDAC who consented to genomic tumor testing and underwent preoperative imaging and curative intent surgical resection from December 2006 to July 2017. Two radiologists assessed preoperative CT imaging using the APA/SAR PDAC-reporting template. Univariable associations between overall survival and imaging variables were evaluated using Cox proportional hazards regression. Results: The study included 168 patients (66 years ± 11; 91 women). 126/168 patients (75%) received upfront surgical resection whereas 42/168 (25%) received neoadjuvant therapy prior to surgical resection. In the entire cohort, features associated with decreased overall survival were tumor arterial contact of any kind (hazard ratio (HR) 1.89, 95% CI 1.13–3.14, p = 0.020), tumor contact with the common hepatic artery (HR 2.33, 95% CI 1.35–4.04, p = 0.009), and portal vein deformity (HR 3.22, 95% CI 1.63–6.37, p = 0.003). In the upfront surgical group, larger tumor size was associated with decreased overall survival (HR 2.30, 95% CI 1.19–4.42, p = 0.013). In the neoadjuvant therapy group, the presence of venous collaterals was the only feature associated with decreased overall survival (HR 2.28, 95% CI 1.04–4.99, p = 0.042). Conclusion: The application of the APA/SAR pancreatic adenocarcinoma reporting template may identify predictors of survival that can aid in preoperative stratification of patients. Graphic abstract: [Figure not available: see fulltext.]
AB - Purpose: To evaluate the associations between computed tomography (CT) imaging features extracted from the structured American Pancreatic Association (APA)/Society of Abdominal Radiology (SAR) template and overall survival in patients with resected pancreatic ductal adenocarcinoma (PDAC). Methods: This retrospective analysis included consecutive patients with PDAC who consented to genomic tumor testing and underwent preoperative imaging and curative intent surgical resection from December 2006 to July 2017. Two radiologists assessed preoperative CT imaging using the APA/SAR PDAC-reporting template. Univariable associations between overall survival and imaging variables were evaluated using Cox proportional hazards regression. Results: The study included 168 patients (66 years ± 11; 91 women). 126/168 patients (75%) received upfront surgical resection whereas 42/168 (25%) received neoadjuvant therapy prior to surgical resection. In the entire cohort, features associated with decreased overall survival were tumor arterial contact of any kind (hazard ratio (HR) 1.89, 95% CI 1.13–3.14, p = 0.020), tumor contact with the common hepatic artery (HR 2.33, 95% CI 1.35–4.04, p = 0.009), and portal vein deformity (HR 3.22, 95% CI 1.63–6.37, p = 0.003). In the upfront surgical group, larger tumor size was associated with decreased overall survival (HR 2.30, 95% CI 1.19–4.42, p = 0.013). In the neoadjuvant therapy group, the presence of venous collaterals was the only feature associated with decreased overall survival (HR 2.28, 95% CI 1.04–4.99, p = 0.042). Conclusion: The application of the APA/SAR pancreatic adenocarcinoma reporting template may identify predictors of survival that can aid in preoperative stratification of patients. Graphic abstract: [Figure not available: see fulltext.]
KW - Carcinoma
KW - Neoadjuvant therapy
KW - Neoplasm staging
KW - Pancreatic carcinoma
KW - Pancreatic ductal
KW - Survival analysis
KW - Tomography
KW - X-ray computed
UR - https://www.scopus.com/pages/publications/85091607388
UR - https://www.scopus.com/pages/publications/85091607388#tab=citedBy
U2 - 10.1007/s00261-020-02726-w
DO - 10.1007/s00261-020-02726-w
M3 - Article
C2 - 32986175
AN - SCOPUS:85091607388
SN - 2366-004X
VL - 46
SP - 1607
EP - 1617
JO - Abdominal Radiology
JF - Abdominal Radiology
IS - 4
ER -